Compugen Ltd. Sustainability Profile
Compugen Ltd., a leading biotechnology company headquartered in Israel (IL), has been at the forefront of immuno-oncology since its establishment in 1993. With a strong focus on discovering and developing innovative therapeutic solutions, Compugen operates primarily in the fields of cancer immunotherapy and autoimmune diseases. The company is renowned for its unique approach to drug discovery, leveraging proprietary computational biology platforms to identify novel targets and biomarkers. Compugen's core products include monoclonal antibodies and immune checkpoint inhibitors, which have shown promising results in clinical trials. With a robust pipeline and strategic partnerships, Compugen has positioned itself as a key player in the biotechnology sector, continually striving to advance patient care through cutting-edge research and development.
DitchCarbon Score
How does Compugen Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Compugen Ltd.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Compugen Ltd.'s reported carbon emissions
Compugen Ltd., headquartered in Israel (IL), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Compugen may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As a result, the company's climate commitments remain unclear, and it appears that they have not yet set measurable goals for emissions reduction or sustainability practices.
How Carbon Intensive is Compugen Ltd.'s Industry?
How Carbon Intensive is Compugen Ltd.'s Location?
Compugen Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Compugen Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
